To study important epitopes on glycoprotein E2 of Sindbis virus, eight variants selected to be singly or multiply resistant to six neutralizing monoclonal antibodies reactive against E2, as well as four revertants which had regained sensitivity to neutralization, were sequenced throughout the E2 region. To study antigenic determinants in glycoprotein El, four variants selected for resistance to a neutralizing monoclonal antibody reactive with El were sequenced throughout the E2 and El regions. All of the salient changes in E2 occurred within a relatively small region between amino acids 181 and 216, a domain that encompasses a glycosylation site at residue 196 and that is rich in charged amino acids. Almost all variants had a change in charge, suggesting that the charged nature of this domain is important for interaction with antibodies. Variants independently isolated for resistance to the same antibody were usually altered in the same amino acid, and reversion to sensitivity occurred at the sites of the original mutations, but did not always restore the parental amino acid. The characteristics of this region suggest that this domain is found on the surface of E2 and constitutes a prominent antigenic domain that interacts directly with neutralizing antibodies. Previous studies have shown that this domain is also important for penetration of cells and for virulence of the virus. Resistance to the single El-specffic neutralizing monoclonal antibody resulted from changes of Gly-132 of El to either Arg or Glu. Analogous to the findings with E2, these changes result in a change in charge and are found near a glycosylation site at residue 139. This domain of El may therefore be found near the 181 to 216 domain of E2 on the surface of the El-E2 heterodimer; together, they could form a domain important in virus penetration and neutralization.
In recent years many panels of monoclonal antibodies (MAbs) have been isolated that are specific for the surface proteins of viruses. Of particular interest are antibodies that neutralize infectivity. Mechanisms of neutralization by antibodies are not well understood at present, but in many cases neutralizing antibodies are thought to exert their effect by interfering with virus attachment to susceptible host cells. Some neutralizing antibodies appear to bind directly to the receptor-binding site on the virus, and anti-idiotypic antibodies made to such neutralizing antibodies may function as antireceptor antibodies (4, 9, 46) . Other neutralizing antibodies block binding by reacting with variable regions that are close but not identical to the virus receptor-binding site, because the highly conserved binding site is hidden or protected from interaction with antibody molecules (30, 47) . Some neutralizing antibodies do not block virus attachment, but appear to prevent penetration in some way (28) . In a number of cases, neutralizing MAbs can confer passive protection to disease, indicating that these antibodies react with the virus within the animal and that the epitopes involved are immunologically important in protection against disease (1, 18, 32, 39) . The epitopes with which MAbs react have been mapped in a number of ways, including competitive-binding studies, use of truncated peptides produced in bacteria, and study of the reactivity of synthetic peptides made to the amino acid sequence of the surface proteins (12, 17, 29, 33) . The last two approaches have been of limited usefulness since many epitopes are at least in part conformational, involving structural features absent in short peptides or involving discontinuous portions of the protein.
A complementary approach for mapping antigenic sites has been to isolate virus variants which are resistant to particular MAbs and to determine the change responsible for the resistance (11, 15, 22, 35, 42, 45, 48) . A single-amino-acid change may confer complete resistance to neutralization by an antibody because the amino acid involved is an important if not dominant element of the epitope, even in the case of dispersed or conformational epitopes. Cases have been described, however, in which single-amino-acid substitutions in regions away from the actual antibody-binding site itself have led to escape from neutralization, because the substitution leads to a change in conformation of the epitope (21) .
Several panels of MAbs that are reactive with the glycoproteins of Sindbis virus or of other alphaviruses have been isolated (3, 18, 26, 27, 32, 33, 38, 49) . As has been the case for polyclonal antisera made to the isolated glycoproteins, antibodies which are specific for glycoprotein El, the hemagglutinin, may react with both the virus and the isolated protein and may inhibit hemagglutination by virus and hemadsorption by infected cells, but seldom neutralize infectivity. On the other hand, E2-specific antibodies are often neutralizing. To further characterize their MAbs, Stec et al. (40) isolated Sindbis virus variants which were resistant to each of five different E2-specific neutralizing MAbs and to one El-specific neutralizing MAb. In some cases, variants b Primers with the prefix RD were kindly supplied by R. K. Durbin (7) . Other primers were synthesized in our facility.
showed resistance to other MAbs in addition to the one with which they were selected. Their results demonstrated the existence of at least two independently mutable epitopes on E2 and showed that isolates sequentially selected with more than one antibody acquired multiple resistance. To facilitate the analysis and rule out exogenous mutations unrelated to antigenic reactivity, Stec et al. (40) then isolated revertants of several of these antigenic escape variants that were once again susceptible to neutralization by the original antibody. To localize the changes responsible for altered antibody reactivity, we have sequenced relevant regions of the genomic RNA of the parental AR339 strain of Sindbis virus and of 12 variants (either singly or multiply resistant), as well as four revertants. A preliminary description of some of these results has appeared (42) .
MATERIALS AND METHODS
Virus strains. The parental Sindbis virus from which antigenic variants were isolated was the AR339 strain, obtained from Joel Dalrymple. The virus was plaque purified three times in Vero cells before isolation of antibody escape variants. It is slightly different from the AR339 strain supplied by the American Type Culture Collection (ATCC), as described in Results. The heat-resistant strain of Sindbis virus (HR) was originally isolated from the AR339 strain by Burge and Pfefferkom (2) . In 1972, large-plaque (LP) and small-plaque (SP) strains of Sindbis virus HR were separated in our laboratory. The complete sequence of Sindbis virus HRSP RNA has been reported (41) , as well as the sequence of the structural-protein region of HRLP (24) . The isolation of Sindbis virus AR339 variants resistant to MAbs and of revertants that were again sensitive to the selecting MAb has been described previously (40) .
RNA preparations. Seed virus stocks were prepared on chicken embryo fibroblast monolayers as previously described (23) . For RNA preparation, two or three roller bottles (800 cm2) were infected with virus at a multiplicity of 10 in phosphate-buffered saline (PBS) (containing Ca and Mg) (6) with 1% fetal calf serum and 1 ,ug of dactinomycin per ml. After a 1-h adsorption at 37°C, the inocula were removed and replaced with Eagle medium containing 3% fetal calf serum and 1 ,ug of dactinomycin per ml. After 3 h at 37°C, the medium was replaced with fresh medium lacking dactinomycin, and 1 mCi of [3H]uridine (New England Nuclear) was added to one bottle. At 7 h after infection the monolayers were washed with ice-cold PBS and the cells were scraped from the glass with rubber policemen. The cells were washed with high-salt buffer [0.5 M NaCl, 15 mM MgCl2, 5 mM ethylene glycol-bis(P3-aminoethyl ether)-N,N, N',N'-tetraacetic acid (EGTA), 50 mM piperazine-N,N'-bis (2-ethanesulfonic acid) (PIPES) (pH 6.5)] and lysed with 1% Nonidet P-40 in high-salt buffer, and the nuclei and unlysed cells were removed by centrifugation (20) . The supernatant was made 1% in sodium dodecyl sulfate (SDS), and total cellular RNA was prepared by phenol extraction as previously described (20, 31 We conclude that all six E2-specific MAbs used here bind to closely spaced or overlapping epitopes and that the epitope recognized by the El-specific MAb 33 is found close to these E2 neutralizing epitopes, at least in intact virus. Interference between MAbs 33 and 18 is maintained even in Triton-disrupted virions, for which it has been shown previously that El-E2 heterodimers are maintained (25, 50) .
Reactivity of the variants with MAbs. By using this panel of neutralizing MAbs, Stec et MAb 33  MAb 3  49  50  43  23  18  30  51  R6  R13   AR339  100  100  100  100  100  100  100  100  100  100  100  v18  100  100  100  <50  <1  <1  <1  NDd  ND  100  100  v30  100  100  100  100  100  <1  <1  ND  ND  100  100  v51  100  100  ND  <1  <1  <1  <1  ND  ND  100  100  v5O  <50  <1  <1  100  100  100  100  100  100  100  100  v23  100  100  100  <1  <1  <1  <1  100  100  100  100  v33  100  100  100  100  100  100  100  100 Reactivities are indicated in percentages as follows: 100 indicates reactivity equal to that of the AR339 parent; -80 indicates reactivity reduced 10 to 50%, presumably as a result of lower avidity; <50 indicates reactivity reduced more than 50%; <1 indicates a strain completely resistant to the antibody. Reactivities were determined by ELISA, as described previously (40 Fig. 2 . The locations of the differences between the parental AR339 strain and each of the variants are indicated. Also indicated on this figure are sequence differences between the parental AR339 strain used to generate the variants, the ATCC AR339 strain (16) , and the HRSP strain (41 (Fig. 2) . It is interesting that two of these differences are shared with the AR339 strain supplied by the ATCC (16) .
The AR339 strain was isolated in Egypt in 1953 (43) ; the sequence data are consistent with the hypothesis that the Dalrymple strain is a lower-passage stock than the ATCC strain and that the substitutions at amino acids 157 and 399 occurred during passage in tissue culture.
A change from A to U at nucleotide 9987, changing Ile-30 to Phe in the 55-amino-acid protein (6K protein), was also found in v33 and its derivatives, but is lacking in v23/33. This change appears to be unrelated to antigenicity and is presumably an extraneous change that was fixed upon plaque purification.
Characterization of variants resistant to neutralizing MAbs that are reactive with E2. Figure 3 shows the regions within E2 sequenced in all of the variants. Several have been sequenced throughout the E2 region. For other variants, when the pattern of alterations became clear, the sequence of E2 has been determined only from the amino terminus through the region in which all of the MAb-selected differences have been found (the heavily shaded domain between amino acids 170 and 220). It seems unlikely that additional alterations outside of the regions sequenced influence the antigenic response of these variants. (41) and ATCC AR339 strain (16) , showing the nucleotide and amino acid differences from the AR339 strain obtained from Dalrymple.
of the E2 changes in HRSP distinguishing it from AR339 (positions 3, 172, and The variability of this region is also illustrated by the fact that in a stretch of 36 amino acids, changes in six different residues, all but one involving a change in charge, have been found that confer resistance to one or another of the MAbs examined (Fig. 6) . Furthermore, four other amino acids in the 50-residue domain illustrated in Fig. 6 have been found to vary in different strains of Sindbis virus, as shown; three of these also involve changes in charge. Thus the sequence in this domain is flexible in that many changes are tolerated, including many changes in charge.
Even though two neutralization epitopes, A and B, can be defined from the pattern of cross-reaction of resistant variants, it is clear that these epitopes are overlapping and interrelated. First, competition experiments showed that all A-and B-specific MAbs tested compete for binding (Fig. 1) (38) found that 10 of 12 MAbs in a panel specific for E2 would discriminate between two strains of Sindbis virus that differed in their neurovirulence for mice. These two strains were later found to differ at only two positions in E2, residues 55 and 209 (16) , and both changes (His-55 to Gln and Gly-209 to Arg) involve charge alterations. The epitopes with which these MAbs react have not been mapped, and it is unclear whether residues 55 and 209 represent contact residues for the MAbs studied by Stanley et al. (38) or whether these two changes might induce conformational changes within E2 or the E1-E2 heterodimer that lead to differences in reactivity with multiple antibodies responding to different epitopes.
The domain of E2 identified by these studies as an important antigenic site is very likely to be involved in binding of the virus to susceptible cells and in the virulence of the virus. An anti-idiotypic antibody to MAb 49 appears to function as a high-affinity antireceptor antibody in chicken cells, and anti-idiotypic antibodies to MAbs 23 and 50 appear to be low-affinity antireceptor antibodies (46) . This suggests that this domain plays a major role during binding of the virus to receptors on susceptible cells. Furthermore, two strains of Sindbis virus that differ only by having Gly or Arg at position 172 of E2 differ in their neurovirulence for mice (16) and in their ability to bind to cultured neuroblastoma cells (44) , consistent with the hypothesis that this domain is important for binding to cellular receptors and suggesting that differences in neurovirulence may arise from differences in receptor affinities.
The work reported here has also identified a domain in El near a glycosylation site as being important for neutralization and presumably forming a neutralization epitope. Neutralizing antibodies that interact with El are comparatively rare. Anti-El MAbs isolated by Schmaljohn et al. (32, 33) were mapped to five spatially distinct epitopes by competitive binding studies. Only one epitope (defined by MAb 33) led to virus neutralization, and we show here that the change from Gly-132 to Arg or Glu renders variants resistant to this MAb. These variants grow poorly compared with the parental virus, at least under the conditions used here to prepare viral RNA, suggesting these changes are not neutral. The functional unit in the virus glycoprotein spike is the E1-E2 heterodimer (8, 25, 50) , and the antireceptor on the virus that binds to the cellular receptor may be composed of domains derived from both El and E2. The competition studies reported here suggest that the El-specific neutralization domain defined by MAb 33 (presumably near residue 132) and the E2-specific neutralization domain defined by MAbs 49, 50, 23, 18, 30 
